Which major pharmaceutical merger, completed in January 2019, was valued at approximately $74 billion and brought together two companies with complementary oncology portfolios?

In the world of pharmaceutical companies, mergers and acquisitions reshape the landscape of medical research, drug development, and patient care. One of the largest pharmaceutical mergers in history occurred in 2019, creating a powerhouse in oncology and immunology treatments. This merger represented a significant consolidation in the medical industry, bringing together complementary portfolios of prescription medications and creating new opportunities for drug development. Test your knowledge about this industry-changing deal!

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Bristol-Myers Squibb's acquisition of Celgene
Takeda Pharmaceutical's acquisition of Shire
AbbVie's acquisition of Allergan
Pfizer's merger with Mylan (forming Viatris)